Contact

Are you a health worker?

Contact

Are you a health worker?

Etorikoksib JGL, a novelty in the prescription portfolio

1 min of reading Published: 19.2.2019.

JGL’s prescription portfolio has been expanded with an analgesic from the “Anti-inflammatory and antirheumatic products” pharmacotherapeutic group, with the brand name:

Etorikoksib JGL 60 mg film-coated tablets

Etorikoksib JGL 90 mg film-coated tablets

(etoricoxib)

14×60 mg, 14×90 mg

The product is indicated in adults and adolescents over the age of 16 for alleviating symptoms of chronic and acute pain in the following approved indications: osteoarthitis, rheumatoid arthritis and ankylosing spondylitis, pain and signs of inflammation related to acute uric arthritis (gout), and shortterm treatment of pain following a dental surgery procedure. Etorikoksib JGL is included in the CIHI supplemental list of drugs.

Read more:

Etorikoksib JGL 60 mg film-coated tablets

Etorikoksib JGL 90 mg film-coated tablets

This page uses cookies to ensure a better user experience and site functionality. By continuing to view this website you agree to the use of cookies.

You can read more about privacy and personal data here